Welgene Biotech (6661) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 威健生技

Welgene Biotech (6661) reported revenue of NT$33.9 million for Oct 2026, +22.2% year on year and -4.5% from the previous month. Revenue for Jan–Oct 2026 was NT$325.9 million (+6.5% year on year).

In Oct 2026, it ranked No. 114 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$24.9 million24/10Nov 2024 NT$29.5 millionDec 2024 NT$33.2 millionJan 2025 NT$22.6 millionFeb 2025 NT$26.8 million25/02Mar 2025 NT$28.5 millionApr 2025 NT$24.5 millionMay 2025 NT$32.3 millionJun 2025 NT$33.2 million25/06Jul 2025 NT$33.4 millionAug 2025 NT$46.9 millionSep 2025 NT$29.7 millionOct 2025 NT$27.8 million25/10Nov 2025 NT$34.1 millionDec 2025 NT$36 millionJan 2026 NT$29 millionFeb 2026 NT$26 million26/02Mar 2026 NT$28.8 millionApr 2026 NT$30.8 millionMay 2026 NT$43.1 millionJun 2026 NT$33.3 million26/06Jul 2026 NT$33.2 millionAug 2026 NT$32.3 millionSep 2026 NT$35.5 millionOct 2026 NT$33.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$33.9 million+22.2%-4.5%
Sep 2026NT$35.5 million+19.6%+10.2%
Aug 2026NT$32.3 million-31.2%-2.7%
Jul 2026NT$33.2 million-0.9%-0.3%
Jun 2026NT$33.3 million+0.1%-22.9%
May 2026NT$43.1 million+33.4%+40.0%
Apr 2026NT$30.8 million+25.5%+7.1%
Mar 2026NT$28.8 million+0.9%+10.7%
Feb 2026NT$26 million-2.9%-10.5%
Jan 2026NT$29 million+28.2%-19.3%
Dec 2025NT$36 million+8.2%+5.4%
Nov 2025NT$34.1 million+15.6%+22.9%
Oct 2025NT$27.8 million+11.5%-6.6%
Sep 2025NT$29.7 million+28.9%-36.7%
Aug 2025NT$46.9 million+94.0%+40.3%
Jul 2025NT$33.4 million-22.6%+0.6%
Jun 2025NT$33.2 million+43.7%+2.8%
May 2025NT$32.3 million-2.9%+31.8%
Apr 2025NT$24.5 million+25.3%-13.9%
Mar 2025NT$28.5 million+28.3%+6.5%
Feb 2025NT$26.8 million+32.6%+18.3%
Jan 2025NT$22.6 million-13.0%-31.9%
Dec 2024NT$33.2 million+24.1%+12.6%
Nov 2024NT$29.5 million+17.1%+18.5%
Oct 2024NT$24.9 million+15.0%+8.0%

Jan–Oct 2026 cumulative: NT$325.9 million (+6.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Welgene Biotech vs PEC / Welgene Biotech vs Lotus Pharm / Welgene Biotech vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16